NCT00517426View on ClinicalTrials.gov

Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

August 31, 2012

Conditions
Chronic Heart Failure
Interventions
DRUG

acetazolamide

i.v. 500 mg of acetazolamide for the acute study and 500 mg of acetazolamide p.o. t.i.d. for two days

Trial Locations (1)

20138

Centro Cardiologico Monzino, University of Milan, Milan

All Listed Sponsors
lead

Centro Cardiologico Monzino

OTHER

NCT00517426 - Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart Failure | Biotech Hunter | Biotech Hunter